Spdr S&p Biotech Etf ETF Forecast

Buy candidate since Jun 11, 2026 Gain 0.79%

The SPDR S&P Biotech ETF price gained 0.791% on the last trading day (Friday, 12th Jun 2026), rising from $132.74 to $133.79. During the last trading day the ETF fluctuated 1.94% from a day low at $132.96 to a day high of $135.54. The price has been going up and down for this period, and there has been a -2.12% loss for the last 2 weeks. Volume fell on the last day by -2 million shares and in total, 8 million shares were bought and sold for approximately $1.04 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 6.96% during the next 3 months and, with a 90% probability hold a price between $138.33 and $154.55 at the end of this 3-month period.

XBI Signals & Forecast

Mostly positive signals in the chart today. The SPDR S&P Biotech ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF, but the ETF has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $131.04 and $132.35. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 5.52%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely.

Support, Risk & Stop-loss for SPDR S&P Biotech ETF

SPDR S&P Biotech finds support from accumulated volume at $128.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved $2.58 (1.94%) between high and low. For the last week, the ETF has had daily average volatility of 3.17%.

Our recommended stop-loss: $126.96 (-5.11%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (XBI) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect SPDR S&P Biotech ETF to open at $134.10, and during the day (based on 14 day Average True Range), to move between $131.86 and $135.72, which gives a possible trading interval of +/-$3.86 (+/-2.93%) up or down from last closing price. If SPDR S&P Biotech ETF takes out the full calculated possible swing range there will be an estimated 2.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $134.71 (0.69%) than the support at $128.85 (3.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SPDR S&P Biotech ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SPDR S&P Biotech ETF to perform well in the short-term.

Current score: 1.505 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $134.10 ( 0.229%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk